• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Ultrasound Biomicroscopy of Patients With Hemorrhagic Complications Following Intravitreal Anti-Vascular Endothelial Growth Factor Injection.玻璃体内注射抗血管内皮生长因子后出血性并发症患者的超声生物显微镜检查
J Vitreoretin Dis. 2025 Aug 28:24741264251364011. doi: 10.1177/24741264251364011.
2
Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.抗血管内皮生长因子预防增殖性糖尿病视网膜病变玻璃体切除术后玻璃体腔出血
Cochrane Database Syst Rev. 2015 Aug 7;2015(8):CD008214. doi: 10.1002/14651858.CD008214.pub3.
3
Ocriplasmin for symptomatic vitreomacular adhesion.用于有症状性玻璃体黄斑粘连的奥克纤溶酶
Cochrane Database Syst Rev. 2017 Oct 17;10(10):CD011874. doi: 10.1002/14651858.CD011874.pub2.
4
Anti-VEGF drugs compared with laser photocoagulation for the treatment of proliferative diabetic retinopathy: a systematic review and individual participant data meta-analysis.抗血管内皮生长因子药物与激光光凝术治疗增殖性糖尿病视网膜病变的比较:一项系统评价和个体参与者数据荟萃分析
Health Technol Assess. 2025 Apr 2:1-75. doi: 10.3310/MJYP6578.
5
Anti-vascular endothelial growth factor for neovascular glaucoma.抗血管内皮生长因子治疗新生血管性青光眼。
Cochrane Database Syst Rev. 2023 Apr 3;4(4):CD007920. doi: 10.1002/14651858.CD007920.pub4.
6
Clinical Characteristics and Treatment Outcomes of Breakthrough Vitreous Hemorrhage in Peripheral Exudative Hemorrhagic Chorioretinopathy (PEHCR).周边渗出性出血性脉络膜视网膜病变(PEHCR)中突破性玻璃体积血的临床特征与治疗结果
Clin Ophthalmol. 2025 Aug 19;19:2821-2833. doi: 10.2147/OPTH.S535257. eCollection 2025.
7
Anti-VEGF drugs compared with laser photocoagulation for the treatment of diabetic retinopathy: a systematic review and economic analysis.抗血管内皮生长因子药物与激光光凝术治疗糖尿病视网膜病变的比较:系统评价与经济分析
Health Technol Assess. 2025 May 7:1-16. doi: 10.3310/KRWP1264.
8
Anti-VEGF drugs compared with laser photocoagulation for the treatment of diabetic retinopathy: a systematic review and meta-analysis.抗血管内皮生长因子药物与激光光凝术治疗糖尿病性视网膜病变的比较:一项系统评价和荟萃分析。
Health Technol Assess. 2024 Dec 11:1-71. doi: 10.3310/PCGV5709.
9
Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.抗血管内皮生长因子治疗视网膜分支静脉阻塞继发的黄斑水肿。
Cochrane Database Syst Rev. 2013 Jan 31(1):CD009510. doi: 10.1002/14651858.CD009510.pub2.
10
Anti-vascular endothelial growth factor for proliferative diabetic retinopathy.抗血管内皮生长因子治疗增殖性糖尿病视网膜病变
Cochrane Database Syst Rev. 2014 Nov 24;2014(11):CD008721. doi: 10.1002/14651858.CD008721.pub2.

本文引用的文献

1
Analysis of urgent follow up visits and complications after intravitreal injections: a retrospective cohort study.玻璃体内注射后紧急随访就诊及并发症分析:一项回顾性队列研究。
Int J Retina Vitreous. 2022 Jan 18;8(1):8. doi: 10.1186/s40942-021-00358-w.
2
Characteristics and surgical outcomes of rhegmatogenous retinal detachments that develop after intravitreal injections.眼内注射后发生的孔源性视网膜脱离的特征和手术结果。
Jpn J Ophthalmol. 2021 Jul;65(4):492-496. doi: 10.1007/s10384-021-00834-8. Epub 2021 Mar 21.
3
Frequency of Rhegmatogenous Retinal Detachment after Intravitreal Therapy in Neovascular Age-Related Macular Degeneration.新生血管性年龄相关性黄斑变性患者玻璃体内治疗后孔源性视网膜脱离的频率。
Ophthalmol Retina. 2020 Oct;4(10):973-978. doi: 10.1016/j.oret.2020.03.028. Epub 2020 Apr 14.
4
Rhegmatogenous Retinal Detachment after Intravitreal Injection of Anti-Vascular Endothelial Growth Factor.抗血管内皮生长因子眼内注射后引起的孔源性视网膜脱离。
Ophthalmology. 2019 Oct;126(10):1424-1431. doi: 10.1016/j.ophtha.2019.04.037. Epub 2019 Apr 28.
5
Vitreous incarceration after ranibizumab injection: an ultrasound biomicroscopy study.雷珠单抗注射后玻璃体嵌顿:一项超声生物显微镜研究
Ophthalmic Surg Lasers Imaging Retina. 2015 Apr;46(4):471-4. doi: 10.3928/23258160-20150422-11.
6
Translational public health care perspective: intravitreal treatment of neovascular age-related macular degeneration has revolutionized clinical ophthalmology.转化性公共卫生保健视角:玻璃体内注射治疗新生血管性年龄相关性黄斑变性彻底改变了临床眼科。
Acta Ophthalmol. 2015 Mar;93(2):103-4. doi: 10.1111/aos.12680.
7
Association between systemic anticoagulation and rate of intraocular hemorrhage following intravitreal anti-VEGF therapy for age-related macular degeneration.全身抗凝与抗血管内皮生长因子(VEGF)玻璃体内注射治疗年龄相关性黄斑变性后眼内出血发生率之间的关联
Ophthalmic Surg Lasers Imaging Retina. 2013 Sep-Oct;44(5):455-9. doi: 10.3928/23258160-20130909-06.
8
Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature.抗血管内皮生长因子药物玻璃体内注射相关的不良反应和并发症:文献复习。
Eye (Lond). 2013 Jul;27(7):787-94. doi: 10.1038/eye.2013.107. Epub 2013 May 31.
9
Ocular complications after anti-vascular endothelial growth factor therapy in Medicare patients with age-related macular degeneration.老年黄斑变性医疗保险患者接受抗血管内皮生长因子治疗后的眼部并发症。
Am J Ophthalmol. 2011 Aug;152(2):266-72. doi: 10.1016/j.ajo.2011.01.053. Epub 2011 Jun 12.
10
Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES).玻璃体内注射贝伐单抗(阿瓦斯汀)的12个月安全性:泛美视网膜协作研究组(PACORES)的结果
Graefes Arch Clin Exp Ophthalmol. 2008 Jan;246(1):81-7. doi: 10.1007/s00417-007-0660-z. Epub 2007 Aug 3.

玻璃体内注射抗血管内皮生长因子后出血性并发症患者的超声生物显微镜检查

Ultrasound Biomicroscopy of Patients With Hemorrhagic Complications Following Intravitreal Anti-Vascular Endothelial Growth Factor Injection.

作者信息

Antonietti Michael, Schwartz Stephen G, Aguero Lazaro, Flynn Harry W

机构信息

Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA.

出版信息

J Vitreoretin Dis. 2025 Aug 28:24741264251364011. doi: 10.1177/24741264251364011.

DOI:10.1177/24741264251364011
PMID:40893338
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12394209/
Abstract

To describe a case series of patients who experienced hemorrhagic complications following intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections. In a small case series of 3 patients with retinal disorders, imaging with ultrasound biomicroscopy (UBM) was performed within 1 day following anti-VEGF injection. The first patient had a mild vitreous hemorrhage, and UBM demonstrated a suspected needle track through the pars plana; the hemorrhage cleared spontaneously. The second patient had a dense vitreous hemorrhage as well as hyphema, and UBM demonstrated a suspected needle track through the pars plicata; the hemorrhage did not clear and the patient was subsequently treated elsewhere with pars plana vitrectomy. The third patient had a subconjunctival hemorrhage but no vitreous hemorrhage, and UBM demonstrated no definite evidence of a needle track. In some patients with vitreous hemorrhage following anti-VEGF injection, a suspected needle track may be imaged with UBM within 1 day following injection.

摘要

描述一系列在玻璃体内注射抗血管内皮生长因子(抗VEGF)后出现出血并发症的患者情况。在一个由3例视网膜疾病患者组成的小病例系列中,于抗VEGF注射后1天内进行了超声生物显微镜(UBM)成像检查。首例患者发生轻度玻璃体积血,UBM显示有一条疑似经睫状体扁平部的针道;出血自行吸收。第二例患者发生浓密的玻璃体积血以及前房积血,UBM显示有一条疑似经睫状襞的针道;出血未吸收,该患者随后转至其他地方接受了睫状体扁平部玻璃体切除术治疗。第三例患者发生结膜下出血但无玻璃体积血,UBM未显示明确的针道证据。在一些抗VEGF注射后发生玻璃体积血的患者中,注射后1天内用UBM可能会成像出疑似针道。